Preparation of Tetrandrine Nanocrystals by Microfluidic Method and Its In Vitro and In Vivo Evaluation

被引:2
|
作者
Huang, Jinping [1 ]
Huang, Shuwen [2 ]
Liu, Shengjun [1 ]
Feng, Lizhen [1 ]
Huang, Wenxiu [1 ]
Wang, Yao [1 ]
Huang, Dongyi [1 ]
Huang, Tingting [1 ]
Huang, Xingzhen [1 ,3 ]
机构
[1] Guangxi Med Univ, Pharmaceut Coll, Nanning 530021, Peoples R China
[2] Guangxi Med Univ, Affiliated Hosp 1, Nanning 530021, Peoples R China
[3] Guangxi Med Univ, Guangxi Key Lab Bioact Mol Res & Evaluat, Nanning 530021, Peoples R China
关键词
glycyrrhetinic acid; hepatocellular carcinoma; microfluidics; nanocrystals; tetrandrine; HYBRID PACLITAXEL NANOCRYSTALS; SERUM-ALBUMIN NANOPARTICLES; TISSUE DISTRIBUTION; LIVER; GLYCYRRHIZIN; PROGRESS; DELIVERY; PHARMACOKINETICS; OPTIMIZATION; TRANSPORT;
D O I
10.1208/s12249-023-02718-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The anti-hepatocellular carcinoma effects of TET are acknowledged, but its application is hindered by its poor water solubility and low bioavailability. Conventional methods for nanocrystal preparation are laborious and lack control. To address these limitations, we propose employing the microfluidic method in the preparation of TET nanocrystals, aiming to enhance the aforementioned constraints. The objectives of this study were to prepare TET nanocrystals (TET-NC@GL) using a Y-microfluidic method with glycyrrhetinic acid (GL) as a stabilizer. The optimal preparation prescription was determined through a single-factor test and Box-Behnken response surface method. Additionally, the nanocrystals prepared with the commonly used stabilizer polyvinylpyrrolidone K30 (PVPK30), known as TET-NC@PVPK30, were characterized and evaluated for their toxicity to HepG2 cells. Hybridized nanocrystals (TET-HNC@GL and TET-HNC@PVPK30) were synthesized using a water-soluble aggregation-induced emission (AIE) fluorescent probe (TVP). Qualitative and quantitative cellular uptake experiments were conducted using these hybridized nanocrystals. Conducting in vivo pharmacokinetic assays evaluates the relative bioavailability of nanocrystals. The results indicated that TET-NC@GL, optimized using the response surface method, had a particle size of 136.47 +/- 3.31 nm and a PDI of 0.219 +/- 0.002. The administration of TET-NC@GL significantly enhanced the cell inhibition rate compared to the TET group and the TET-NC@PVPK30 group (P < 0.01). Moreover, the qualitative and quantitative cellular uptake results revealed a significant enhancement in cellular uptake in the TET-HNC@GL administration group compared to the TET-HNC@PVPK30 group (P < 0.01). In vivo pharmacokinetic results showed that the bioavailability of TET-NC@GL group was 3.5 times higher than that of the TET group. The results demonstrate the successful preparation of TET-NC@GL nanocrystals.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation
    Rui Liu
    Shuangshuang Wang
    Shiming Fang
    Jialu Wang
    Jingjing Chen
    Xingguo Huang
    Xin He
    Changxiao Liu
    Nanoscale Research Letters, 2016, 11
  • [22] Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation
    Liu, Rui
    Wang, Shuangshuang
    Fang, Shiming
    Wang, Jialu
    Chen, Jingjing
    Huang, Xingguo
    He, Xin
    Liu, Changxiao
    NANOSCALE RESEARCH LETTERS, 2016, 11
  • [23] Preparation of a 99mTc-labeled graft polymer and its in vitro and in vivo evaluation
    Uğur Avcıbaşı
    Taner Türkyarar
    Ayşegül Karadağ
    Buket Bakan
    Nefise Ülkü Karabay Yavaşoğlu
    Kevser Kuşat
    Sinan Akgöl
    Derya Gülcemal
    Volkan Tekin
    Fazilet Zümrüt Biber Müftüler
    Gökcen Topal
    Yasemin Parlak
    Fikriye Gül Gümüşer
    Journal of Radioanalytical and Nuclear Chemistry, 2021, 329 : 511 - 525
  • [24] Preparation of novel solid lipid microparticles loaded with gentamicin and its evaluation in vitro and in vivo
    Umeyor, Emmanuel Chukwuebuka
    Kenechukwu, Franklin Chimaobi
    Ogbonna, John Dike
    Chime, Salome Amarachi
    Attama, Anthony
    JOURNAL OF MICROENCAPSULATION, 2012, 29 (03) : 296 - 307
  • [25] Preparation of a 99mTc-labeled graft polymer and its in vitro and in vivo evaluation
    Avcibasi, Ugur
    Turkyarar, Taner
    Karadag, Aysegul
    Bakan, Buket
    Yavasoglu, Nefise Ulku Karabay
    Kusat, Kevser
    Akgol, Sinan
    Gulcemal, Derya
    Tekin, Volkan
    Muftuler, Fazilet Zumrut Biber
    Topal, Gokcen
    Parlak, Yasemin
    Gumuser, Fikriye Gul
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2021, 329 (02) : 511 - 525
  • [26] In vitro evaluation and in vivo demonstration of a biomimetic, hemocompatible, microfluidic artificial lung
    Kovach, K. M.
    LaBarbera, M. A.
    Moyer, M. C.
    Cmolik, B. L.
    van Lunteren, E.
    Gupta, A. Sen
    Capadona, J. R.
    Potkay, J. A.
    LAB ON A CHIP, 2015, 15 (05) : 1366 - 1375
  • [27] Formulation, optimization, and in vitro-in vivo evaluation of olmesartan medoxomil nanocrystals
    Jain, Sanyog
    Patel, Kamlesh
    Arora, Sumit
    Reddy, Venkata Appa
    Dora, Chander Parkash
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2017, 7 (02) : 292 - 303
  • [28] Hyperoside nanocrystals for HBV treatment: process optimization, in vitro and in vivo evaluation
    Shen, Baode
    Wu, Na
    Shen, Chengying
    Zhang, Fucheng
    Wu, Yan
    Xu, Pinghua
    Zhang, Lihong
    Wu, Wei
    Lu, Yi
    Han, Jin
    Wang, Yonggang
    Yuan, Hailong
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (11) : 1772 - 1781
  • [29] Chronotherapeutically Modulated Pulsatile System of Valsartan Nanocrystals—an In Vitro and In Vivo Evaluation
    Nikhil Biswas
    Ketousetuo Kuotsu
    AAPS PharmSciTech, 2017, 18 : 349 - 357
  • [30] Preparation and evaluation of SEDDS of simvastatin by in vivo, in vitro and ex vivo technique
    Karim, Fahim Tamzeedul
    Kalam, Azad
    Anwar, Rafi
    Miah, Muhammad Masum
    Rahman, Md Shamim
    Islam, S. M. Ashraful
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (08) : 1338 - 1342